DE60121981D1 - Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung - Google Patents

Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung

Info

Publication number
DE60121981D1
DE60121981D1 DE60121981T DE60121981T DE60121981D1 DE 60121981 D1 DE60121981 D1 DE 60121981D1 DE 60121981 T DE60121981 T DE 60121981T DE 60121981 T DE60121981 T DE 60121981T DE 60121981 D1 DE60121981 D1 DE 60121981D1
Authority
DE
Germany
Prior art keywords
cornstarch
dysglucaemia
granulate
tablets
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121981T
Other languages
English (en)
Inventor
Henri Hansson
Kerstin Hansson
Mats Lake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metcon Medicin AB
Original Assignee
Metcon Medicin AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0003877A external-priority patent/SE0003877D0/xx
Application filed by Metcon Medicin AB filed Critical Metcon Medicin AB
Application granted granted Critical
Publication of DE60121981D1 publication Critical patent/DE60121981D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE60121981T 2000-10-25 2001-10-24 Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung Expired - Lifetime DE60121981D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24307200P 2000-10-25 2000-10-25
SE0003877A SE0003877D0 (sv) 2000-10-25 2000-10-25 New composition, method and use
PCT/SE2001/002326 WO2002034271A1 (en) 2000-10-25 2001-10-24 New composition and method for the treatment of dysglucaemia

Publications (1)

Publication Number Publication Date
DE60121981D1 true DE60121981D1 (de) 2006-09-14

Family

ID=26655276

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121981T Expired - Lifetime DE60121981D1 (de) 2000-10-25 2001-10-24 Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (4) US6815433B2 (de)
EP (1) EP1328280B1 (de)
JP (1) JP2004512306A (de)
AT (1) ATE334688T1 (de)
AU (2) AU9619601A (de)
CA (1) CA2422900A1 (de)
DE (1) DE60121981D1 (de)
WO (1) WO2002034271A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9619601A (en) * 2000-10-25 2002-05-06 Metcon Medicin Ab New composition and method for the treatment of dysglucaemia
US20030158090A1 (en) * 2001-07-23 2003-08-21 Ulrik Pedersen-Bjergaard Renin-angiotensin system in diabetes mellitus
SE0200539D0 (sv) * 2002-02-25 2002-02-25 Metcon Medicin Ab Granulation process and starch granulate
US20050054611A1 (en) * 2002-09-13 2005-03-10 Mats Lake Composition and method for use in intestinal cleansing procedures
GB0325942D0 (en) 2003-11-06 2003-12-10 Glycologic Ltd Compositions and uses thereof
SE0402084D0 (sv) * 2004-08-26 2004-08-26 Metcon Medicin Ab Method and composition for long-term glycemic control
CN101237874B (zh) * 2005-07-05 2013-10-09 努特里希亚公司 碳水化合物成分及其在获得平稳的餐后葡萄糖响应中的应用
US8557274B2 (en) * 2005-12-06 2013-10-15 Purdue Research Foundation Slowly digesting starch and fermentable fiber
EP2068636A4 (de) * 2006-09-18 2010-09-29 Purdue Research Foundation Gelockerte produkte, die aus nichtweizen-getreideproteinen hergestellt sind
US8283338B2 (en) 2007-11-30 2012-10-09 Kao Corporation GIP secretion inhibitor
JP5871447B2 (ja) * 2007-11-30 2016-03-01 花王株式会社 Ｇｉｐ分泌抑制剤
ES2393310T3 (es) 2007-12-03 2012-12-20 Varatus Vongsurakrai Método para producir polvo cosmético y/o dermatológico
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US8338389B2 (en) 2009-06-17 2012-12-25 Kao Corporation Agent for preventing or ameliorating obesity
MX2013004364A (es) 2010-10-19 2013-07-02 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
CZ2013338A3 (cs) * 2013-05-09 2014-11-19 Veterinární A Farmaceutická Univerzita Brno Farmaceutická kompozice s řízeným uvolňováním metabolicky aktivního cukru

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886295A (en) * 1974-01-04 1975-05-27 Tee Pak Inc Low calorie synthetic seasoning
US4262031A (en) * 1979-08-17 1981-04-14 General Foods Corporation Cooked pudding composition containing highly-dutched cocoa and process
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5360614A (en) 1993-04-26 1994-11-01 The Estee Corporation Method of controlling the release of carbohydrates by encapsulation and composition therefor
US5605893A (en) 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
IL112967A0 (en) * 1994-03-15 1995-06-29 Los Angeles Childrens Hospital Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
US5843921A (en) * 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
JP3110299B2 (ja) * 1994-10-27 2000-11-20 武田薬品工業株式会社 成形物およびその製造方法
JP3119801B2 (ja) * 1995-09-28 2000-12-25 武田薬品工業株式会社 ビタミン含有組成物の安定化方法
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
US5842931A (en) 1996-02-12 1998-12-01 Payne; Edward D. Mirrored headgear sports training system
US5866555A (en) * 1997-03-12 1999-02-02 Beth Israel Deaconess Medical Center Diabetic supplement bar
US6316427B1 (en) * 2000-04-04 2001-11-13 Metcon Medicin Ab Treatment for diabetes
AU9619601A (en) * 2000-10-25 2002-05-06 Metcon Medicin Ab New composition and method for the treatment of dysglucaemia

Also Published As

Publication number Publication date
EP1328280A1 (de) 2003-07-23
ATE334688T1 (de) 2006-08-15
US20050070502A1 (en) 2005-03-31
WO2002034271A1 (en) 2002-05-02
JP2004512306A (ja) 2004-04-22
CA2422900A1 (en) 2002-05-02
US20040198699A1 (en) 2004-10-07
EP1328280B1 (de) 2006-08-02
US20020094971A1 (en) 2002-07-18
AU2001296196B2 (en) 2006-07-06
US6815433B2 (en) 2004-11-09
US20030004135A1 (en) 2003-01-02
AU9619601A (en) 2002-05-06
US6815436B2 (en) 2004-11-09

Similar Documents

Publication Publication Date Title
DE60121981D1 (de) Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung
HK1247107A1 (zh) 控制血糖水平的營養組合物
DE60001745D1 (de) Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin mit glucocerebrosidase enzyme zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten
JP4295840B2 (ja) 血行改善剤
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
JP2008056688A (ja) ピペリジン及びピロリジン
JP2005513079A5 (de)
HUP0300642A2 (hu) Antidiabetikus készítmény és alkalmazása
ATE216394T1 (de) Paclitaxel prodrogen, verfahren zur herstellung und ihre verwendung zur selektiven chemotherapie
WO2000030446A1 (en) Dosage formulations for acetylcholinesterase inhibitors
US4309445A (en) d-Fenfluramine for modifying feeding behavior
CN104208654A (zh) 一种以地龙蛋白提取物为主的保健配方
WO1999015643A3 (en) ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE
GEP20053540B (en) Matrix Tablet for Sustained Release of Trimetazidine after Oral Administration
CN101466354A (zh) Ⅱ型糖尿病组合物干胶片
NO20054380L (no) Arylsykloalkylderivater med forgrenede sidekjeder som PPAR-reseptormodulatorer, deres fremstilling og deres anvendelse som legemiddel
JP2004331576A (ja) 急激な血糖値の上昇を抑制する血糖値上昇抑制剤及び食品
Yamamoto et al. Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats
Birkmayer et al. L-dopa level in plasma, primary condition for the kinetic effect
Zhang et al. The effects of food components on the digestion of DNA by pepsin
TW200510399A (en) 1, 3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups; processes for their preparation and their use as pharmaceuticals
JP2020100601A (ja) 一酸化窒素合成酵素活性化剤
WO2002043566A3 (en) Devices and methods for treating low blood sugar levels
US6683098B1 (en) Use of drug miglitol (Glyset) for treatment of obesity to prevent weight gain for losing weight and for weight control
CN1282484C (zh) 一种降脂药物组合物

Legal Events

Date Code Title Description
8332 No legal effect for de